ReviewFrontiers in endocrinology2026
AI-enabled precision evaluation of adrenal masses: radiomics, deep learning, and explainable imaging biomarkers.
Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate evaluation of adrenal masses remains a significant challenge in endocrinology and radiology, as differential diagnosis involves a wide spectrum of benign and malignant lesions. Radiomics and deep learning (DL) have emerged as promising tools to enhance the precision of adrenal mass assessment by extracting high-dimensional imaging features and enabling automated, data-driven analysis. This review summarizes the latest advancements in the application of radiomics and DL techniques for adrenal mass evaluation. We systematically describe the workflow of radiomic feature extraction and model development, emphasizing their roles in differentiating key lesions such as pheochromocytomas/paragangliomas (PPGLs), adrenal cortical adenomas, and adrenal cortical carcinomas. Additionally, the utility of these approaches in genotype prediction and prognostic evaluation is highlighted. The review further explores the advantages and potential of DL, particularly convolutional neural networks (CNNs), in automated segmentation, feature learning, and end-to-end diagnostic frameworks. Finally, current challenges including technical limitations, clinical translation barriers, and future research directions are discussed, aiming to provide a theoretical foundation for constructing intelligent and precise adrenal mass evaluation systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.